Could your marathon training be putting you at risk? New research reveals a concerning link between marathon running and a higher incidence of colorectal cancer among athletes. Discover the findings and what they mean for fitness enthusiasts.
Doctors are pushing the FDA to remove black box warnings on low-dose estrogen treatments, arguing it discourages women from beneficial hormone therapies for menopause. Experts claim the risks are overstated and can hinder treatment.
A groundbreaking study reveals how structured exercise can significantly reduce cancer recurrence and improve survival rates for patients. Discover why incorporating exercise into recovery is crucial for cancer patients.
Appendix cancer diagnoses are on the rise, particularly among younger adults. Experts are puzzled by this trend and urge awareness of vague symptoms that could indicate this rare disease. Learn more about the potential causes and prevention strategies.
A groundbreaking study reveals that increasing fiber intake may help eliminate harmful 'forever chemicals' from the body, reducing cancer risks. Learn how simple dietary changes can make a difference.
A new study finds that long-distance runners aged 35 to 50 are at a higher risk of developing colon cancer, with alarming rates of precancerous tumors detected. Experts urge runners to get tested for early signs.
A groundbreaking study shows that GLP-1 diabetes drugs may reduce the risk of obesity-related cancers by 7% compared to DPP-4 inhibitors, particularly in women. Discover the implications for diabetes treatment!
Prostate cancer is a significant health concern for men, but early detection can save lives. Explore the risk factors, early symptoms, and innovative testing methods that could help in timely diagnosis.
A new study warns that food packaging, including so-called eco-friendly options, may increase cancer risk and other health issues due to harmful chemicals leaching into food. Experts urge immediate action!
A landmark study reveals that weight-loss injections may significantly reduce the risk of obesity-related cancers, potentially transforming preventive medicine. The findings suggest that GLP-1 receptor agonists could halve cancer risk, prompting calls for further research.
